Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia

被引:6
|
作者
Li, Jingyu [1 ]
Cai, Ailu [1 ]
Yuan, Qian [1 ]
Ding, Hao [1 ]
Zhao, Dan [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang, Liaoning, Peoples R China
关键词
Fetal Doppler; Placental growth factor; Pre-eclampsia; Serum biomarkers; Soluble fms-like tyrosine kinase-1; Uterine artery Doppler; ANGIOGENIC FACTORS; DYSFUNCTION; PREDICTION; MANIFESTATIONS; BIOMARKERS; ULTRASOUND; PREGNANCY; DIAGNOSIS; SFLT-1; ONSET;
D O I
10.1002/ijgo.12796
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To compare serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) concentrations among women with pre-eclampsia and healthy control women and to evaluate the associations of serum PlGF and sFlt-1 with fetal and uterine artery Doppler indices in pre-eclampsia. Methods A prospective cross-sectional study of 33 women with pre-eclampsia and 33 normotensive pregnant women attending a university hospital in China between January and November 2014. Serum PlGF and sFlt-1 were assayed by enzyme linked immunosorbent assays. Doppler indices of the uterine artery, umbilical artery, fetal middle cerebral artery, and ductus venosus were measured. Results The pulsatility index of the uterine artery was negatively correlated with PlGF (r, -0.487; P=0.004) and positively correlated with sFlt-1 (r, 0.420; P=0.015). Gestational age at birth was positively correlated with PlGF (r, 0.601, P<0.001) and negatively correlated with sFlt-1 (r, -0.568; P=0.001). Birth weight was positively correlated with PlGF (r, 0.555; P=0.001) and negatively correlated with sFlt-1 (r, -0.552; P=0.001). Apgar score was negatively correlated with sFlt-1 (r, -0.427; P=0.017). Conclusion Lower PlGF and higher sFlt-1 levels in maternal serum were significantly associated with increased uterine arterial impedance in pre-eclampsia.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [41] First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy
    Schneuer, Francisco J.
    Nassar, Natasha
    Guilbert, Cyrille
    Tasevski, Vitomir
    Ashton, Anthony W.
    Morris, Jonathan M.
    Roberts, Christine L.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (04) : 215 - 221
  • [42] In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies
    Holme, Ane M.
    Roland, Marie C. P.
    Henriksen, Tore
    Michelsen, Trond M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (06)
  • [43] Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women
    Wataganara, Tuangsit
    Pratumvinit, Busadee
    Lahfahroengron, Piyaporn
    Pooliam, Julaporn
    Talungchit, Pattarawalai
    Leetheeragul, Jarunee
    Sukpanichnant, Sathien
    JOURNAL OF PERINATAL MEDICINE, 2017, 45 (07) : 895 - 901
  • [44] Stability of serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1)
    Lian, Ingrid Alsos
    Dypdalsbakk, Tone
    Asberg, Arne
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2024, 84 (03): : 160 - 167
  • [45] Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction
    Shinohara, Satoshi
    Uchida, Yuzo
    Kasai, Mayuko
    Sunami, Rei
    HYPERTENSION IN PREGNANCY, 2017, 36 (03) : 269 - 275
  • [46] Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester
    Chelli, Dalenda
    Hamdi, Asma
    Saoudi, Sarah
    Jenayah, Amel A.
    Zagre, Armand
    Jguerim, Haithem
    Bedis, Channoufi
    Sfar, Ezzeddine
    CLINICAL LABORATORY, 2016, 62 (10) : 1927 - 1932
  • [47] Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
    Hastie, Roxanne
    Bergman, Lina
    Walker, Susan P.
    Kaitu'u-Lino, Tu'uhevaha
    Hannan, Natalie J.
    Brownfoot, Fiona
    Schell, Sonja
    Harper, Alesia
    Cannon, Ping
    Cluver, Catherine A.
    Tong, Stephen
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (16):
  • [48] Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies
    Liu, Yuxiu
    Zhao, Yang
    Yu, Ailing
    Zhao, Bin
    Gao, Yufang
    Niu, Haitao
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (03) : 507 - 518
  • [49] Influences on Placental Growth Factor (PlGF) and Soluble fms-like Tyrosine Kinase-1 (sFlt-1) Concentration Levels at the Time of First Trimester Screening
    von See, J.
    Limperger, V.
    Pecks, U.
    Eckmann-Scholz, C.
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2016, 220 (04): : 166 - 171
  • [50] Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study
    Rizos, Demetrios
    Eleftheriades, Makarios
    Karampas, Gregory
    Rizou, Myrto
    Haliassos, Alexander
    Hassiakos, Dimitrios
    Vitoratos, Nikolaos
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 171 (02) : 225 - 230